AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 294: F1323-F1335, 2008. First published April 2, 2008; doi:10.1152/ajprenal.00401.2007
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/6/F1323    most recent
00401.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Diaz Encarnacion, M. M.
Right arrow Articles by Grande, J. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diaz Encarnacion, M. M.
Right arrow Articles by Grande, J. P.

Signaling pathways modulated by fish oil in salt-sensitive hypertension

Montserrat M. Diaz Encarnacion,1 Gina M. Warner,1 Catherine E. Gray,1 Jingfei Cheng,1 Hesham K. H. Keryakos,1 Karl A. Nath,2 and Joseph P. Grande1,2

1Department of Laboratory Medicine and Pathology and 2Division of Nephrology, Mayo Clinic College of Medicine, Rochester, Minnesota

Submitted 29 August 2007 ; accepted in final form 1 April 2008

Although many studies have indicated that fish oil (FO) improves cardiovascular risk factors and reduces histopathological manifestations of injury in experimental renal injury models, potential mechanisms underlying this protective effect have not been adequately defined. The objective of this study was to identify potential signaling pathways that confer protection in the Dahl rat model of salt-sensitive hypertension. Male Dahl salt-sensitive rats (n = 10/group) were provided with formulated diets containing 8% NaCl, 20% protein, and 25% FO or 25% corn oil (CO) for 28 days. FO reduced blood pressure (–11% at 4 wk; P < 0.05), urine protein excretion (–45% at 4 wk; P < 0.05), plasma cholesterol and triglyceride levels (–54%, P < 0.001; and –58%, P < 0.05), and histopathological manifestations of renal injury, including vascular hypertrophy, segmental and global glomerular sclerosis, interstitial fibrosis, and tubular atrophy. Interstitial inflammation was significantly reduced by FO (–32%; P < 0.001), as assessed by quantitative analysis of ED1-positive cells in sections of the renal cortex. FO reduced tubulointerstitial proliferative activity, as assessed by Western blot analysis of cortical homogenates for PCNA (–51%; P < 0.01) and quantitative analysis of Mib-1-stained sections of the renal cortex (–42%; P < 0.001). Decreased proliferative activity was associated with reduced phospho-ERK expression (–37%; P < 0.005) and NF-{kappa}B activation (–42%; P < 0.05). FO reduced cyclooxygenase (COX)-2 expression (–63%; P < 0.01) and membrane translocation of the NADPH oxidase subunits p47phox and p67phox (–26 and –34%; P < 0.05). We propose that FO ameliorates renal injury in Dahl salt-sensitive rats through the inhibition of ERK, decreased NF-{kappa}B activation, inhibition of COX-2 expression, and decreased NADPH oxidase activation.

fibrosis; glomerulosclerosis; docosahexaenoic acid; eicosapentaenoic acid; rat



Address for reprint requests and other correspondence: J. P. Grande, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905 (e-mail: grande.joseph{at}mayo.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.